Study number 8539-627
Dates
Jan 19 2026-Mar 03 2026
Location
Daytona Beach, Florida
Age
18-65
Gender
Male or Female
Smoker
No
Compensation
$11,228
Group
Part 2 Group 5a OR 5b
This is a research study for an investigational drug being developed for the treatment of Primary Sjögren’s Syndrome, an autoimmune disorder in which the immune system mistakenly attacks healthy cells in the body.
Fortrea Daytona Beach, FL is recruiting for:
- Healthy Non-Smoking Adults, age 18-65
- Body Mass Index between 18.5-30
- Study involves 1 stay of 18 overnights & 1 follow-up visit*& 1 phone call
- Compensation up to $11,228 may be provided for time and participation*
- Refer a friend to receive $350 per qualified referral
*Additional out-patient visits may be required at the end of the study, resulting in additional compensation of up to
$174 per additional visit.
Call Now to Schedule Your Screening Appointment!
Part 2 Group 5a:
Check-in: Jan 19
Check-out: Feb 6
Follow up Visit: Feb 14
Phone Call: Mar 3
OR
Part 2 Group 5b:
Check-in: Jan 21
Check-out: Feb 8
Follow up Visit: Feb 16
Phone Call: Mar 5